Literature DB >> 9462441

MICs of rifampicin and chloramphenicol for mucoid Pseudomonas aeruginosa strains are lower when human lactoferrin is present.

C E Fowler1, J S Soothill, L Oakes.   

Abstract

MlCs of rifampicin and chloramphenicol for mucoid strains of Pseudomonas aeruginosa were lower in the presence of human lactoferrin (0.9 mg/mL, the concentration found in cystic fibrosis sputum) than in its absence. MICs for some strains were lowered to clinically achievable levels of the antibiotics, which is compatible with impressions of greater clinical efficacy in pseudomonas infections than would be predicted by standard sensitivity tests. The routine addition of lactoferrin to sensitivity media for testing of cystic fibrosis isolates may give more useful results than conventional tests as in-vivo conditions are more closely simulated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462441     DOI: 10.1093/jac/40.6.877

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Antibiotic susceptibility of Stenotrophomonas maltophilia in the presence of lactoferrin.

Authors:  Ahmed O Qamruddin; Mustafa A Alkawash; James S Soothill
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Local release of antibiotics for surgical site infection management using high-purity calcium sulfate: an in vitro elution study.

Authors:  Sean S Aiken; John J Cooper; Hannah Florance; Matthew T Robinson; Stephen Michell
Journal:  Surg Infect (Larchmt)       Date:  2014-08-22       Impact factor: 2.150

3.  Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  María T Andrés; Mónica Viejo-Diaz; Francisco Pérez; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 4.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

5.  Neolactoferrin as a stimulator of innate and adaptive immunity.

Authors:  A D Chernousov; M F Nikonova; N I Sharova; A N Mitin; M M Litvina; P E Sadchikov; I L Goldman; A A Yarilin; E R Sadchikova
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

Review 6.  Lactoferrin in a Context of Inflammation-Induced Pathology.

Authors:  Marian L Kruzel; Michal Zimecki; Jeffrey K Actor
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.